Abstract
Most lung cancer patients are unfortunately uncurable and die because of widespread metastases, thus indicating the importance of identification of molecules with a crucial role in this process. Our previous expression profiling analysis of a highly metastatic lung cancer cell line, NCI-H460-LNM35, and its parental low metastatic line, NCI-H460-N15, revealed significant up-regulation of both known and unknown genes in LNM35. In this study, we describe the isolation and detailed characterizations of a novel gene, named CLCP1, which corresponds to one of such expression sequence tags with up-regulated expression in LNM35. The CLCP1 gene was found to encode a protein with 775 amino acids with structural similarities to, but distinct from neuropilins, cell surface receptors for VEGF165 and semaphorins. Notably, CLCP1 was shown to be up-regulated not only in LNM35 in association with its acquisition of metastatic phenotype during in vivo selection, but also in a significant fraction of lung cancers in vivo with high frequency in metastatic lesions, warranting future studies for a better understanding of the molecular mechanisms of lung cancer metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM . 2001 Cancer Res. 61: 5736–5740
Bagnard D, Lohrum M, Uziel D, Puschel AW, Bolz J . 1998 Development 125: 5043–5053
Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC . 1996 Nature 383: 525–528
Bork P, Beckmann G . 1993 J. Mol. Biol. 231: 539–545
Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M . 1997 Neuron 19: 547–559
Fidler IJ, Kerbel RS, Ellis LM . 2001 Biology of Cancer: Angiogenesis: Cancer Principles and Practice of Oncology 6th edn DeVita Jr VT, Hellman S and Rosenberg SA (eds) Philadelphia: Lippincott Williams & Wilkins pp 917–925
Frohman MA . 1993 Methods Enzymol. 218: 340–356
Fujisawa H, Kitsukawa T . 1998 Curr. Opin. Neurobiol. 8: 587–592
Hayashibara T, Yamada Y, Miyanashi T, Mori H, Joh T, Maeda T, Mori N, Maita T, Kamihira S, Tomonaga M . 2001 Clin. Cancer Res. 7: 2719–2726
He Z, Tessier-Lavigne M . 1997 Cell 90: 739–751
Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD . 1997 Cell 90: 753–762
Kolodkin AL, Matthes DJ, Goodman CS . 1993 Cell 75: 1389–1399
Kozaki K, Koshikawa K, Tatematsu Y, Miyaishi O, Saito H, Hida T, Osada H, Takahashi T . 2001 Oncogene 20: 4228–4234
Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T . 2000 Cancer Res. 60: 2535–2540
Liotta LA, Kohn EC . 2001 Nature 411: 375–379
Luo Y, Raible D, Raper JA . 1993 Cell 75: 217–227
Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS . 2001 Blood 98: 1904–1913
Miao HQ, Klagsbrun M . 2000 Cancer Metas. Rev. 19: 29–37
Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M . 2000 FASEB J. 14: 2532–2539
Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z . 1999 FASEB J. 13: 9–22
Sekido Y, Fong KM, Minna JD . 2001 Cancer of the Lung: Cancer Principles and Practice of Oncology 6th edn DeVita Jr VT, Hellman S and Rosenberg SA (eds) Philadelphia: Lippincott Williams & Wilkins pp 917–925
Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR . 2001 Am. J. Pathol. 159: 651–659
Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M . 1998 Cell 92: 735–745
Springer WR, Cooper DN, Barondes SH . 1984 Cell 39: 557–564
Statistics and Information Department, Minister's Secretariat 1999 Vital Statistics of Japan 1999 Vol. 3 Ministry of Health, Labour and Welfare: Tokyo pp 398–411
Stetler-Stevenson WG, Kleiner Jr DE . 2001 Molecular Biology of Cancer: Invasion and Metastasis: Cancer Principles and Practice of Oncology 6th edn DeVita Jr VT, Hellman S and Rosenberg SA (eds) Philadelphia: Lippincott Williams & Wilkins pp 123–136
Trexler M, Banyai L, Patthy L . 2000 Eur. J. Biochem. 267: 5751–5757
Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K . 2000 Cancer Res. 60: 203–212
Acknowledgements
The GenBank accession number for the CLCP1 cDNA is AB073146. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koshikawa, K., Osada, H., Kozaki, Ki. et al. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene 21, 2822–2828 (2002). https://doi.org/10.1038/sj.onc.1205405
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205405
Keywords
This article is cited by
-
A homozygous nonsense mutation in DCBLD2 is a candidate cause of developmental delay, dysmorphic features and restrictive cardiomyopathy
Scientific Reports (2021)
-
Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma
Journal of Translational Medicine (2020)
-
SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression
Oncogene (2020)
-
Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer
Cellular Oncology (2020)
-
A fast algorithm for Bayesian multi-locus model in genome-wide association studies
Molecular Genetics and Genomics (2017)